EUVIMEDEUVIMED entdecken
Leitlinie

Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO)

Florence Ranchon, Florian Slimano, Isabelle Borget, Mathieu Boulin, Christophe Bardin, Pierre Coliat, Nicolas Cormier, Catherine Devys, Raphaelle Fanciullino, Muriel Paul, Florent Puisset, Catherine Rioufol und 6 weitere

Annales Pharmaceutiques Françaises · 2025-11 · 83 (6) · 1040-1052

DOI: 10.1016/j.pharma.2025.07.005 ↗

Kurz gefasst

Leitlinie in der Zeitschrift Annales Pharmaceutiques Françaises, 2025-11. Verfasst von Florence Ranchon und 17 weiteren Autor:innen. Beteiligte Einrichtung: French Society for Oncology Pharmacy (SFPO), Paris, France; Clinical Oncology Pharmacy Unit, Hospices civils de Lyon, Pierre-Bénite, France; Centre f…. Hauptthemen laut MEDLINE: Oncology Service, Hospital, Pharmacy Service, Hospital, Antineoplastic Agents, Medical Oncology. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 127 Literaturangaben. Gefördert von: Hospices Civils de Lyon, Ministère des Solidarités et de la Santé.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Oncology Service, HospitalPharmacy Service, HospitalAntineoplastic AgentsMedical OncologyNeoplasmsHumansFranceSocieties, PharmaceuticalPrecision MedicineArtificial Intelligence

Stichwörter der Autor:innen

Document de positionOncology pharmacyPharmacie oncologiquePosition paper

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • French Society for Oncology Pharmacy (SFPO), Paris, France; Clinical Oncology Pharmacy Unit, Hospices civils de Lyon, Pierre-Bénite, France; Centre for Innovation in Cancerology of Lyon (CICLY), University Lyon 1, EA 37…
  • French Society for Oncology Pharmacy (SFPO), Paris, France; BioSpeCT, University of Reims Champagne-Ardenne, Reims University Hospital, Pharmacy, Reims, France.
  • French Society for Oncology Pharmacy (SFPO), Paris, France; Biostatistics and Epidemiology Department, Gustave Roussy Institute, University Paris-Saclay, Inserm CESP U1018, Oncostat, accredited by Ligue Contre le Cancer…
  • French Society for Oncology Pharmacy (SFPO), Paris, France; Department of Pharmacy, University Hospital, University of Burgundy, EPICAD LNC UMR1231, Dijon, France.
  • French Society for Oncology Pharmacy (SFPO), Paris, France; Clinical Pharmacy, Cochin University Hospital, AP-HP, Centre-Université Paris-Cité, Paris, France.
  • French Society for Oncology Pharmacy (SFPO), Paris, France; Pharmacy Department, Strasbourg Europe Cancer Institute, Strasbourg, France.

Förderung

  • Hospices Civils de Lyon
  • Ministère des Solidarités et de la Santé

Zitieren

APA

Ranchon, F., Slimano, F., Borget, I., Boulin, M., Bardin, C., Coliat, P., Cormier, N., Devys, C., Fanciullino, R., Paul, M., Puisset, F., Rioufol, C., Tortolano, L., Tournamille, J. F., Vigneron, J., Chevrier, R., Pourroy, B., & Cazin, J. L. (2025). Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO). Annales Pharmaceutiques Françaises, 83(6), 1040-1052. https://doi.org/10.1016/j.pharma.2025.07.005

Vancouver

Ranchon F, Slimano F, Borget I, Boulin M, Bardin C, Coliat P, et al. Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO). Annales Pharmaceutiques Françaises. 2025;83(6):1040-1052. doi:10.1016/j.pharma.2025.07.005

BibTeX
@article{Ranchon2025,
  author = {Ranchon, Florence and Slimano, Florian and Borget, Isabelle and Boulin, Mathieu and Bardin, Christophe and Coliat, Pierre and Cormier, Nicolas and Devys, Catherine and Fanciullino, Raphaelle and Paul, Muriel and Puisset, Florent and Rioufol, Catherine and Tortolano, Lionel and Tournamille, Jean-François and Vigneron, Jean and Chevrier, Régine and Pourroy, Bertrand and Cazin, Jean-Louis},
  title = {Oncology pharmacy practice: Key insights, challenges, and perspectives – A position paper from the French Society for Oncology Pharmacy (SFPO)},
  journal = {Annales Pharmaceutiques Françaises},
  year = {2025},
  volume = {83},
  number = {6},
  pages = {1040--1052},
  doi = {10.1016/j.pharma.2025.07.005}
}
Kostenlos starten →